论文部分内容阅读
目的探讨国产切诺在治疗慢性支气管炎急性发作期的应用价值。方法 98例慢性支气管炎急性发作期患者随机分为切诺组和吉诺通组。在应用抗感染及对症(如退热、平喘)治疗基础上分别加用切诺或吉诺通,用药第3、5、7天记录相关症状,观察其疗效及副作用。结果切诺和吉诺通总有效率分别为92.00%和94.00%,两组疗效及副作用比较无显著性差异,但从具体数值上看,吉诺通略优于切诺。结论国产切诺和进口吉诺通均是治疗慢性支气管炎急性发作期的有效药物,建议临床推荐使用。
Objective To investigate the value of domestic Chernoze in the treatment of acute exacerbation of chronic bronchitis. Methods A total of 98 patients with acute exacerbation of chronic bronchitis were randomly divided into Chernobate and Ginuo Tong group. In the application of anti-infective and symptomatic (such as antipyretic, asthma) treatment, respectively, based on the treatment with Cynanorol or Gynoplant, medication on the 3rd, 5th, 7th days to record the relevant symptoms and observe its curative effect and side effects. Results The overall effective rates of Cynanor and Ginorodon were 92.00% and 94.00%, respectively. There was no significant difference between the two groups in curative effects and side effects. However, Ginorodin slightly outperformed Chernopert on specific values. Conclusion Both domestic Chernobyl and imported Ginolone are effective drugs for the treatment of acute exacerbation of chronic bronchitis, and are recommended for clinical use.